Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02361346
Title Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL (MT-3724NHL001)
Acronym MT-3724NHL001
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Molecular Templates, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | ISR | ESP | CAN


No variant requirements are available.